-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Repligen, Lowers Price Target to $175

Benzinga·07/30/2025 14:11:17
Listen to the news
Wells Fargo analyst Brandon Couillard maintains Repligen (NASDAQ:RGEN) with a Overweight and lowers the price target from $180 to $175.